A tale of pituitary adenomas: to NET or not to NET : Pituitary Society position statement

doi:10.1007/s11102-019-00988-2

Review

. 2019 Dec;22(6):569-573.

doi: 10.1007/s11102-019-00988-2.

A tale of pituitary adenomas: to NET or not to NET : Pituitary Society position statement

Affiliations

¹ The Garvan Institute of Medical Research, St. Vincents Hospital, The University of New South Wales, 384 Victoria Street, Darlinghurst, Sydney, NSW, 2010, Australia. k.ho@garvan.org.au.
² Departments of Medicine and Neurological Surgery, Pituitary Center, Oregon Health & Science University, Portland, OR, USA.
³ Department of Endocrinology, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, UK.
⁴ Pituitary Center Rotterdam, Endocrinology Section, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
⁵ Division of Endocrinology, University of Michigan Health System, Ann Arbor, MI, USA.
⁶ Division of Endocrinology and Metabolism, San Raffaele University Hospital, Milan, Italy.
⁷ Division of Endocrinology, Santiago de Compostela University and Ciber OBN, Santiago, Spain.
⁸ Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
⁹ Division of Endocrinology and Center for Endocrine Tumors, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands.
¹⁰ Department of Medicine for Endocrinology, Diabetes and Nutritional Medicine, Charité Universitätsmedizin, Berlin, Germany.
¹¹ Pituitary Center, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

PMID: 31571098
DOI: 10.1007/s11102-019-00988-2

Review

A tale of pituitary adenomas: to NET or not to NET : Pituitary Society position statement

Ken K Y Ho et al. Pituitary. 2019 Dec.

. 2019 Dec;22(6):569-573.

doi: 10.1007/s11102-019-00988-2.

Authors

Affiliations

¹ The Garvan Institute of Medical Research, St. Vincents Hospital, The University of New South Wales, 384 Victoria Street, Darlinghurst, Sydney, NSW, 2010, Australia. k.ho@garvan.org.au.
² Departments of Medicine and Neurological Surgery, Pituitary Center, Oregon Health & Science University, Portland, OR, USA.
³ Department of Endocrinology, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford, UK.
⁴ Pituitary Center Rotterdam, Endocrinology Section, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
⁵ Division of Endocrinology, University of Michigan Health System, Ann Arbor, MI, USA.
⁶ Division of Endocrinology and Metabolism, San Raffaele University Hospital, Milan, Italy.
⁷ Division of Endocrinology, Santiago de Compostela University and Ciber OBN, Santiago, Spain.
⁸ Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
⁹ Division of Endocrinology and Center for Endocrine Tumors, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands.
¹⁰ Department of Medicine for Endocrinology, Diabetes and Nutritional Medicine, Charité Universitätsmedizin, Berlin, Germany.
¹¹ Pituitary Center, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

PMID: 31571098
DOI: 10.1007/s11102-019-00988-2

No abstract available

Keywords: Neuroendocrine tumor; Pituitary adenoma; Tumor classification.

PubMed Disclaimer

Comment in

Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution.
Asa SL, Asioli S, Bozkurt S, Casar-Borota O, Chinezu L, Comunoglu N, Cossu G, Cusimano M, Delgrange E, Earls P, Ezzat S, Gazioglu N, Grossman A, Guaraldi F, Hickman RA, Ikeda H, Jaffrain-Rea ML, Karavitaki N, Kraljević I, La Rosa S, Manojlović-Gačić E, Maartens N, McCutcheon IE, Messerer M, Mete O, Nishioka H, Oz B, Pakbaz S, Pekmezci M, Perry A, Reiniger L, Roncaroli F, Saeger W, Söylemezoğlu F, Tachibana O, Trouillas J, Turchini J, Uccella S, Villa C, Yamada S, Yarman S. Asa SL, et al. Pituitary. 2020 Jun;23(3):322-325. doi: 10.1007/s11102-019-01015-0. Pituitary. 2020. PMID: 31834538 No abstract available.
The tale in evolution: clarity, consistency and consultation, not contradiction and confusion.
Ho KKY, Fleseriu M, Wass J, van der Lely A, Barkan A, Giustina A, Casanueva FF, Heaney AP, Biermasz N, Strasburger C, Melmed S. Ho KKY, et al. Pituitary. 2020 Aug;23(4):476-477. doi: 10.1007/s11102-019-01027-w. Pituitary. 2020. PMID: 31912348 No abstract available.

Cited by

Trouillas's Grading and Post-Surgical Tumor Residue Assessment in Pituitary Adenomas: The Importance of the Multidisciplinary Approach.
Calandrelli R, Mattogno PP, Chiloiro S, Gessi M, D'Apolito G, Tartaglione T, Giampietro A, Bianchi A, Doglietto F, Lauretti L, Gaudino S. Calandrelli R, et al. Diagnostics (Basel). 2024 Jan 26;14(3):274. doi: 10.3390/diagnostics14030274. Diagnostics (Basel). 2024. PMID: 38337790 Free PMC article.
Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 1, general recommendations.
Korbonits M, Blair JC, Boguslawska A, Ayuk J, Davies JH, Druce MR, Evanson J, Flanagan D, Glynn N, Higham CE, Jacques TS, Sinha S, Simmons I, Thorp N, Swords FM, Storr HL, Spoudeas HA. Korbonits M, et al. Nat Rev Endocrinol. 2024 May;20(5):278-289. doi: 10.1038/s41574-023-00948-8. Epub 2024 Feb 9. Nat Rev Endocrinol. 2024. PMID: 38336897 Review.
Pituitary adenoma classification: Tools to improve the current system.
McDonald WC. McDonald WC. Free Neuropathol. 2024 Jan 10;5:5-2. doi: 10.17879/freeneuropathology-2024-5226. eCollection 2024 Jan. Free Neuropathol. 2024. PMID: 38213550 Free PMC article.
Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification.
Ho KKY, Kaiser UB, Chanson P, Gadelha M, Wass J, Nieman L, Little A, Aghi MK, Raetzman L, Post K, Raverot G, Borowsky AD, Erickson D, Castaño JP, Laws ER, Zatelli MC, Sisco J, Esserman L, Yuen KCJ, Reincke M, Melmed S. Ho KKY, et al. Nat Rev Endocrinol. 2023 Nov;19(11):671-678. doi: 10.1038/s41574-023-00883-8. Epub 2023 Aug 17. Nat Rev Endocrinol. 2023. PMID: 37592077 Review.
Pituitary Neuroendocrine Tumor: Is It Benign or Malignant?
Lee CH. Lee CH. Brain Tumor Res Treat. 2023 Jul;11(3):173-176. doi: 10.14791/btrt.2023.0015. Brain Tumor Res Treat. 2023. PMID: 37550816 Free PMC article. Review.

See all "Cited by" articles

References

1. Endocr Pathol. 2001 Fall;12(3):291-9 - PubMed
1. Nat Rev Endocrinol. 2011 May;7(5):257-66 - PubMed
1. Eur J Endocrinol. 2007 Feb;156(2):203-16 - PubMed
1. World J Surg Oncol. 2016 Apr 30;14:138 - PubMed
1. Neuroendocrinology. 2015;101(2):143-50 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Medical
- MedlinePlus Health Information

[1] Endocr Pathol. 2001 Fall;12(3):291-9 - PubMed

[2] Endocr Pathol. 2001 Fall;12(3):291-9 - PubMed

[3] Nat Rev Endocrinol. 2011 May;7(5):257-66 - PubMed

[4] Nat Rev Endocrinol. 2011 May;7(5):257-66 - PubMed

[5] Eur J Endocrinol. 2007 Feb;156(2):203-16 - PubMed

[6] Eur J Endocrinol. 2007 Feb;156(2):203-16 - PubMed

[7] World J Surg Oncol. 2016 Apr 30;14:138 - PubMed

[8] World J Surg Oncol. 2016 Apr 30;14:138 - PubMed

[9] Neuroendocrinology. 2015;101(2):143-50 - PubMed

[10] Neuroendocrinology. 2015;101(2):143-50 - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

A tale of pituitary adenomas: to NET or not to NET : Pituitary Society position statement

Affiliations

A tale of pituitary adenomas: to NET or not to NET : Pituitary Society position statement

Authors

Affiliations

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical